mobihealthnews.com·Feb 2, 2026
Santé Ventures has raised $330 million for its Fund V, exceeding its $300 million target, to invest in early-stage biotechnology, medical technology, and digital health startups aiming to improve patient care.
Santé Ventures has raised $330 million for its Fund V, exceeding its initial target, to invest in early-stage startups in biotechnology, medical technology, and digital health. This presents a strong investment signal for professionals tracking healthtech and biotech, as the fund focuses on innovative solutions in clinical complexity and outdated care models, highlighting potential opportunities for partnerships or investment in transformative healthcare solutions.